A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease

Research output: Contribution to journalArticle

    Fingerprint

Keywords

  • Anti-infliximab antibody
  • Crohn's disease
  • Inflammatory bowel disease
  • Infliximab
  • Pediatric
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy
  • Medicine(all)

Cite this